Clinical Trial Update: Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and 2 trial evaluating ranibizumab for diabetic macular edema in Chinese patients, focusing on visual outcomes and predictive factors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: UNKNOWN